| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SPIRONOLACTONE | 219494 | 002 | ANDA | SPIRONOLACTONE | TABLET;ORAL | 50MG | No | No | 2025/01/23 | 2025/01/23 | GRAVITI PHARMS | Prescription |
| SPIRONOLACTONE | 219494 | 003 | ANDA | SPIRONOLACTONE | TABLET;ORAL | 100MG | No | No | 2025/01/23 | 2025/01/23 | GRAVITI PHARMS | Prescription |
| SPIRONOLACTONE | 218085 | 001 | ANDA | SPIRONOLACTONE | SUSPENSION;ORAL | 25MG/5ML | No | No | 2025/02/21 | 2025/02/21 | HETERO LABS LTD III | Prescription |
| SPIRONOLACTONE | 217761 | 001 | ANDA | SPIRONOLACTONE | TABLET;ORAL | 25MG | No | No | 2025/07/25 | 2025/07/25 | ANNORA PHARMA | Prescription |
| SPIRONOLACTONE | 217761 | 002 | ANDA | SPIRONOLACTONE | TABLET;ORAL | 50MG | No | No | 2025/07/25 | 2025/07/25 | ANNORA PHARMA | Prescription |
| SPIRONOLACTONE | 217761 | 003 | ANDA | SPIRONOLACTONE | TABLET;ORAL | 100MG | No | No | 2025/07/25 | 2025/07/25 | ANNORA PHARMA | Prescription |